Twin Securities’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-311,549
Closed -$12.3M 18
2023
Q2
$12.3M Buy
+311,549
New +$11M 6.8% 4

Twin Securities's ISEE Position: Q3 2023 in Review

Twin Securities sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 311,549 shares — an estimated $12.3M sold.

Twin Securities first reported a position in ISEE in Q2 2023 and held it in 1 quarter. The position peaked at $12.3M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Twin Securities reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Twin Securities sold 311,549 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $12.3M.
  • Twin Securities first reported a position in IVERIC bio, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Twin Securities's IVERIC bio, Inc. Common Stock position peaked at $12.3M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Twin Securities's 13F filing for Q3 2023, filed 14 Nov 2023.